Fundraising Fox
Hera BioLabs
1 known investors
Find your way into Hera BioLabs
Sign up to see every warm intro you have to Hera BioLabs
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hera BioLabs team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Hera BioLabs provides gene editing technologies and cell line development services for drug discovery researchers. The company offers custom cell line platforms, animal models, and bioprocessing solutions using transposase technology and proprietary tools like the SRG Rat platform and CleanCut GS CHO system.
Founders & leadership
MS
Michael Schlosser, Ph.D.Chief Executive OfficerMichael Schlosser holds a Ph.D. and brings two decades of experience in pharmaceutical R&D strategy, business operations, and drug discovery across small molecules, proteins, and oligonucleotides in both pharmaceutical and contract research settings. He is CEO of Hera BioLabs, which provides gene editing technologies and cell line development services for drug discovery researchers.
Investors · 1
Frequently asked questions
- What does Hera BioLabs do?
- Hera BioLabs provides gene editing technologies and cell line development services for drug discovery researchers. The company offers custom cell line platforms, animal models, and bioprocessing solutions using transposase technology and proprietary tools like the SRG Rat platform and CleanCut GS CHO system.
- Who are Hera BioLabs's investors?
- Hera BioLabs's investors include Bluegrass Angel Venture.